no code implementations • 7 Jun 2022 • Krzysztof Koras, Marcin Możejko, Paulina Szymczak, Eike Staub, Ewa Szczurek
The model combines data for SMILES string representations of anti-cancer drugs, their inhibition profiles against a panel of protein kinases, cell lines biological features and measurements of the sensitivity of the cell lines to the drugs.